2024-06-27T10:34:22-07:00 2023-08-31 990 2022-09-01 581698648 THE TASK FORCE FOR GLOBAL HEALTH INC TASK 4045921430 330 W Ponce de Leon Ave Decatur GA 300303001 Ellen Wild Chief Operating Officer 4046875607 2024-04-01 Ellen Wild 999009999 1 1 11 1 AAL2 X 2022 2023-04-26 12:10:37Z Ellen Wild 330 W Ponce de Leon Ave Decatur GA 30030 95256664 0 X www.taskforce.org X 1986 GA The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery. 11 10 247 1 0 0 106102999 94304004 0 0 -954190 871890 -1636900 -55609 103511909 95120285 20716998 20562970 0 0 28185464 28809511 0 0 80757 38437278 44554801 87339740 93927282 16172169 1193003 94755909 99670376 18908814 22578224 75847095 77092152 The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery. 0 0 21972356 13675594 22149667 Respiratory Virus Prevention (RVP) Programs: COVID-19 Vaccine Implementation Program (CoVIP) In FY23, we received funding from CDC to continue to support up to 41 countries via technical support and/or subawards and we contracted 46 field consultants. During the year, the number of consultants and subawards decreased due to a reduction in funding and decreased need for consultants to support COVID activities but we ended the year with 20 consultants and we are supporting 27 countries via technical support and/subawards to support COVID related activities. The subawards are mainly focused on integrating COVID-19 into routine immune immunization systems. We also funded an additional 5 vaccine effectiveness projects. Specific technical assistance highlights are listed below: 1. Redeployed staff to support outbreaks of polio and other VPD, as well as vaccine introductions, campaigns, and preparedness plans for multiple antigens 2. Completed integration survey and submitted journal article (currently in review) 3. Presented at/participated in technical workshops nationally, regionally, and internationally 4. Led workshops/trainings on topics from infodemic management to rapid community assessment to data quality to AEFI surveillance 5. Contributed to design of Rapid Support Performance Tool for workforce needs "triage" with the workforce development team 6. Consultants served on national integration planning body in (at least) nine countries In August 2023, we received additional funding from the Global Immunization Division at CDC to support a health worker safety project in Zambia and to fund a partner to develop a rapid support performance triage tool. Longer-term Goal: To ensure that targeted low and middle-income countries are able to increase COVID-19 vaccine uptake in order to meet the following objectives: Objectives: 1. Reduce COVID-19 disease burden, 2. Enhance global health security, 3. Strengthen capacity to vaccinate in response to any future epidemic and pandemic threat Key performance indicators for FY23 are listed below: a. Over 2.5M does were administered via direct support in 14 countries, b. Close to 2000 people were mentored by staff and partners, c. We supported Knowledge, Attitudes, Practices and Perceptions surveys in 12 countries, d. We supported COVID-19 Post-Introduction Evaluations in 10 countries which led to program improvement workshops for 5 countries, e. 92% (11/12) of our sub award partners were very satisfied/somewhat satisfied with the sub ward support the country receive, f. 86% (6/7) of our country partners were very satisfied/somewhat satisfied with the technical support they received by our consultants. CARESAFE (A project funded separately to within the CoVIP project) Vaccine Related Events Projects: a. 4 countries -Ghana, Malawi, Uganda and Barbados and b. Adverse Events of Special Interest After Immunization Project: Chile The CARESAFE project exists within the context of the Covid-19 Vaccine Implementation Program (COVIP). This project builds on existing CDC and Task Force for Global Health (TFGH)/Brighton Collaboration (BC) areas of technical expertise. The aim of the CARESAFE Project is to work with low- and middle-income countries (LMIC) to strengthen their capacity for pharmacovigilance of COVID-19 vaccine adverse events following immunization (AEFI)/of special interest (AESI), as well as strengthen the capacity of LMIC to reliably and sustainably monitor the safety of vaccines. The CARESAFE project supports LMICs that have requested CDC support or have worked with CDC or The Task Force on immunization program strengthening in the past. CARESAFE received a Notice of Award from the CDC for FY22 to carry out work in Ethiopia, Chile, and Ghana. These funds were set to expire in September 2023 but the funds were approved to extend until September 2024. This will allow CARESAFE to wrap up activities in Chile in FY24. Partnership for International Vaccine Initiatives (PIVI) Number of PIVI partner countries: 17 (4 are new partner countries) 1. Influenza Vaccine Doses donated: 403,000 ($1,654,290) 2. Number of partner countries that received donated influenza vaccine doses: 12 3. Number of partner countries that received subawards: 12 4. Total sub award funding provided: $858,125 5. Number of partner countries transitioning from PIVI vaccine support: 6 Goal: Reduce the global disease burden from influenza and improve national and global capacity to respond to pandemics and other epidemic threats Objectives: 1. Partner Countries have increased programmatic experience and local evidence to inform government investment in, improvement of, and integration of national influenza vaccination programs 2. PIVI project team facilitates access to reliable and affordable sources of influenza vaccines for distribution to partner countries 3. Partner Countries are able to secure financial and in-kind resources for national influenza vaccination programs in alignment with their sustainability plans 4. Increased number of Partner Countries transitioning from PIVI vaccine support 5. Expanded number of Partner Countries included in PIVI program 15174657 0 15445821 Public Health Informatics Institute (PHII) provided direct services to the U.S. public health system through a cooperative agreement with the Centers for Disease Control (CDC). This funding supported PHII and its partners in efforts to increase the capacity of public health informaticians and other public health leaders and practitioners to improve the collection, management and use of information and information technology for protecting and improving health and reducing disparities. Key activities included providing workforce development and online tools to state and local health departments on the subject of planning and initiating ongoing data modernization efforts; providing training to public health professionals in essential informatics competencies; creating a suite of new trainings for public health professionals sustaining daily operations of jurisdictional immunization information systems; and developing a playbook for assessing child and adolescent health within catchment areas. Additionally, PHII is an ongoing partner on a collaborative Gates Foundation-funded project that is collecting data to reduce childhood mortality across the globe; this project is working on mortality surveillance activities at sites in Asia and Sub-Saharan Africa. PHII is also engaged with USAID funding for ongoing support of their information system for tracking neglected tropical diseases. PHII also launched two new projects this year: one involving an equity and racial justice-centered approach to community data distribution and collection in the U.S., and a Global Fund-funded project to strengthen early warning surveillance systems in several high-priority countries in Africa and Asia. This second project is intended to prepare and protect the global health landscape against future potential pandemics or other public health emergencies. 12965754 208300 12747139 The Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET) Long-term Program Goal Foster a global network of FETPs that addresses worldwide gaps in country and regional epidemiological workforce capacity. Program Partners/Stakeholders/Clients CDC HQ, CDC Epidemic Intelligence Service (EIS), Global field epidemiology training programs (FETPs), Accreditation Working Group, Universidad del Valle (UVG) of Guatemala, NCD Collaborative, GOARN-WHO, AFENET, EMPHNET, SAFETYNET, Central Asia Ministries of Health, South Caucasus Ministries of Health, India EIS, Colorado Center of Excellence, Colorado Public Health Department, One Health Zoonotic Disease Prioritization, COMISCA, REDSEC, REDSUR, Latin American MoHs (e.g. Ecuador MoH), CDC NPHI, Ukraine Public Health Center, Ethiopia Public Health Institute, Burkina Faso MoH, IANPHI, Pakistan NIH, CDC Eastern European and Central Asia regional office, Kyrgyzstan Ministry of Health, CARPHA, Georgia NCDC Program Activities TEPHINET Network Development Initiative, FETP Accreditation, Accreditation Scale-up, Monitoring and evaluation of FETP residents and alumni, Quality Improvement & Accreditation, Strengthening FETP monitoring and evaluation, Regional FETP Communities of practice, TEPHINET FETP Learning Strategy, Development of Health Equity Curriculum, Global FETP Frontline, Intermediate and Advanced support, Update Mentor's Curriculum, Curriculum & e-learning, FETP Training & Alumni Tracking, Support Mobilization of FETP grades, Credential FETP Graduates, Central America Building Capacity for Global Disease Detection, Pakistan COVID-19, Strengthening Early Warning Surveillance in South America, Pan respiratory disease surveillance, One Health curriculum pilot, Border Health Activities, South America Cross, Border ARD Surveillance, Public Health Bulletin-related activities in 5 countries, Ukraine NPHI Building, Critical COVID-19 Workforce Capacity, Georgia Assessing/Strengthening, Excess Deaths - Central Asia. Performance Measures Increased use of accreditation standards and internal quality improvement standards in FETP. Increased global networking and professional opportunities for FETP residents and graduates. Increased knowledge of importance of field epidemiology to health security among global and national partners and stakeholders. Established workgroups to develop governance structure, systems and mechanisms that results in coordinated common goals and objectives at global, regional and country level. Increased preparedness and involvement of FETPs in outbreak investigations, disaster response, and field epidemiology activities. Increased strategic guidance and technical assistance between FETP community members, including alumni and partners, on learning and capacity building related initiatives. Increased cross-border, regional, and global capacity for surveillance, outbreak detection, response and prevention. Regional and global networks have defined roles and work together in coordinated fashion to strengthen programs and FETP capacity. Improved prevention of avoidable pandemics: including naturally occurring outbreaks and intentional or accidental releases. Improved ability to rapidly detect threats early. Improved interconnected global network that can respond rapidly and mobilize effectively to public health threats. Improved preparedness for potential future outbreaks and other highly infectious diseases. Accomplishments with metrics Operational, consulting, workshops and/or training support implemented for FETPs across 6 WHO regions (AFR, AMR, SEAR, EUR, EMR, WPR) and more than 10 countries (Central America, Central Asia, South Caucasus, Vietnam, India, Columbia, Haiti, Kenya, Cameroon, Ecuador, Caribbean Region, Vietnam, Ukraine) Nearly 30 workshops and/or trainings were implemented globally for FETP frontline, intermediate or advanced tier trainees, trainers or mentors in collaboration with regional partners (particularly Caribbean and South American regions), with at least 1 virtual R epi training for Kazakhstan cohorts. 244 contracts executed by TEPHINET for program implementation. 25 global FETPs accredited by Dec 2022. 3414 active users on TEPHIConnect, the only global networking platform for FETPs. 4 new cohorts and/or FETP tiers were launched in 5 countries in the Latin American region (Colombia, Ecuador, Argentina, Chile, and Paraguay) 76 FETPs completed the Annual member survey that provides key FETP metrics such as number of graduates, cohorts, scientific publications, study tracks and program budgets. Supported FETP logistics for field work for at least 27 outbreak investigations in Kazakhstan, Georgia, Colombia, and Ecuador. Over 10 types of disease outbreak investigations supported (Foodborne disease, drug intoxication, enteric diseases, TAD, HCAI, dengue, measles, monkey pox, COVID-19, avian influenza, leptospirosis, bovine rabies, bovine brucellosis, AFP.) Multiple online course language translations supported or implemented to increase FETP knowledge accessibility. Execution of FETP International Nights (April 25-26, 2023) in person at the CDC EIS Conference for the first time since 2019. TEPHINET received 191 total abstracts. 201 attended in-person on night 1 and 234 on night 2. The event was live streamed on YouTube. As of May 3, 2023, night 1 garnered 1.4K views, and night 2, 1K. In partnership with the Executive Secretariat of the Council of Ministers of Health of Central America and the Dominican Republic (SE-COMISCA), TEPHINET held its 11th Global Scientific Conference in Panama from September 4-9, 2022, bringing together 600 in person and virtual attendees from 65 countries. The event featured more than 200 oral and poster presentations from FETP fellows and alumni, 14 plenary and keynote sessions, and 14 pre-conference workshops on topics including learning, quality improvement, emergency response, statistical analysis, impact evaluation and scientific writing. On September 7, 2022, TEPHINET led the second global celebration of the World Field Epidemiology Day, reaching more than 35 million people on social media and through events held across the globe. Two sessions were held during the 11thTEPHINET Global Scientific Conference in Panama, focused on the theme of Empowering Field Epidemiologists for Stronger Health Systems and reaching 600 people. In April 2023, TEPHINET published its 2022 Annual Report with the theme of "The Future of FETP: Building a Sustainable Health Workforce for Pandemic Preparedness and Response." The report was distributed online, and print copies were distributed at the EIS Conference. The report contains 7 stories demonstrating the role of FETPs in outbreak response. In May 2023, TEPHINET launched the theme for the 2023 World Field Epidemiology Day: "Increasing Diversity, Equity and Inclusion in Field Epidemiology." TEPHINET received five requests for assistance from GOARN. Over 230 FETP alumni submitted letters of interest. The South Caucasus Small Grants Program 2022-2023 awarded grants to 5 South Caucasus FELTP Alumni Association members. The topic area for this round of grants was "Emerging and Re Emerging Infectious Diseases". 12 monthly financial reports submitted to BST Project Officer at CDC. 32475015 6679076 30088710 Additional accomplishments were made by other Programs that include the International Trachoma Initiative, Neglected Tropical Diseases, Global Partnership for Zero Leprosy, Children Without Worms, Coalition for Global Hepatitis Elimination, Mectizan Donation Program, Health Campaign Effectiveness, Partnership for Influenza Vaccine Introduction, Global Funders Consortium for Universal Influenza Vaccine Development,Voices for Vaccines, Brighton Collaboration, Polio Eradication Center, Focus Area for Compassion and Ethics, and MedSurplus Alliance. During the year, these programs worked towards preventing, controlling and eliminating diseases such as intestinal worms, leprosy, lymphatic filariasis, polio, river blindness, trachoma and viral hepatitis. The programs also protected the health populations of the people served by building strong health systems that can train qualified disease detectives, build evidence-based structures to get medicines and vaccines to people, and ensure that communities have the supplies and information they need to fight diseases. This is done through disease surveillance, information systems, medicines, medical equipment and supplies, operational research, outbreak response, seasonal influenza and pandemic preparedness, and vaccines. 32475015 6679076 30088710 82587782 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 119 0 247 1 0 1 ET 0 0 0 0 0 0 X 11 10 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 GA X X Daniel N Martins 4046875620 330 W Ponce de Leon Ave Decatur GA 300303001 David A Ross President & CEO 39 1 X 380847 0 36878 Paul Emerson Program Director 40 0 X 308196 0 72068 Patrick O'Carroll President & CEO 39 1 X 328667 0 28737 Mark McKinlay Program Director 39 1.00 X 301102 0 39985 Yao Sodahlon Program Director 40 0 X 258413 0 70509 William P Nichols Exec. VP/COO 39 1 X 295269 0 26997 Vivian Singletary Program Director 40 0 X 263261 0 51865 John Ward Program Director 40 0 X 287860 0 22159 Carl Reddy Program Director 40 0 X 233677 0 71536 Joseph Bresee Program Director 40 0 X 264792 0 24132 Robert Chen Program Director 40 0 X 259816 0 24452 Kris Sarlas Program Director 40 0 X 217226 0 66439 Patrick Lammie Program Director 40 0 X 244318 0 22954 Daniel Martins Chief Financial Officer 39 1 X 180099 0 65737 Fabien Diomande Program Director 40 0 X 162511 0 62903 Ellen Wild Director of Business Strategy 39 1 X 188520 0 18114 Kent Alexander Board Chair 1 0 X 0 0 0 Charles H McTier Board Member 1 0 X 0 0 0 James Jackson Board Member 1 0 X 0 0 0 Deborah Kilpatrick Board Member 1 0 X 0 0 0 Walter Orenstein Board Member 1 0 X 0 0 0 Walter Deriso Jr Board Member 1 0 X 0 0 0 Geeta Manek Board Member 1 0 X 0 0 0 Bushra Sayed-Ganguly Board Member 1 0 X 0 0 0 Teri Plummer McClure Board Chair 1 0 X 0 0 0 4174574 0 705465 75 1 1 0 Sydani Initiative for International Development 1422 Independence Avenue Central Business District Abuja NI Build an integrated warehouse for essential health data 2576181 The Aurum Institute NPC 29 Queens Road Parktown Gauteng SF 2193 Evaluation GVAX Project in Amathole, Northwest, Tshwane SA 1589460 Leapley Construction Group of Atlanta LLC 180 Interstate North Parkway Suit 140 Atlanta GA 30339 Building Construction Services 1205985 Association Soutoura Kalaban ran near Rond Point Konare Airport Road Rue 87 Porte 33 Bamako ML Assess COVID-19 vaccination efforts in Mali 985164 Southeast European Center for Surveillance & Control (SECID) Institue of Public Health Rruga Ale Rruga Aleksander Moisiu Nr 80 Tirana AL Improving influenza monitoring communications 797946 151 0 0 0 0 63870674 30433330 0 94304004 0 871890 871890 0 0 0 0 0 0 0 0 0 0 80770 0 136379 0 -55609 0 -55609 -55609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 95120285 816281 0 0 0 0 0 0 20562970 20562970 0 0 3775559 1992422 1783137 0 0 0 0 0 19380910 15256939 4093584 30387 1319450 1038690 278691 2069 2978055 2224401 749115 4539 1355537 1067099 286313 2125 30657070 29936314 695736 25020 32060 16343 15717 0 28897 1897 27000 0 0 0 0 0 0 0 52057 13173 38884 0 0 0 0 0 0 0 0 0 633893 375063 258830 0 810037 332612 464465 12960 0 0 0 0 525719 22333 503386 0 4505544 4204584 300960 0 0 0 0 0 3215648 2991997 223651 0 141423 0 141423 0 0 0 0 0 1056264 0 1056264 0 164364 1428 162936 0 Other direct expenses 2460184 2413154 47030 0 Bank charges 37684 36752 932 0 Dues and subscriptions 175845 88942 83246 3657 Miscellaneous 58112 10669 47443 0 93927282 82587782 11258743 80757 0 0 37727493 34150722 7241826 5144115 0 0 0 0 0 0 0 0 0 0 835474 1227390 34627635 7261407 23888723 27366228 25062393 28383823 0 0 0 0 0 0 0 3398098 94755909 99670376 4437518 3151546 0 0 0 0 0 0 0 0 0 0 6613381 11848326 0 0 7857915 7578352 18908814 22578224 X 30932517 34334020 44914578 42758132 75847095 77092152 94755909 99670376 1193003 0 0 52054 0 0 X 0 1 X 1 1 1 X 47166232 45641975 66108782 87003329 95172342 341092660 0 0 0 0 0 0 0 0 0 0 0 0 47166232 45641975 66108782 87003329 95172342 341092660 94953996 246138664 1189041 1398485 1499153 -525598 1377764 4938845 -222353 -598040 -1540029 -1636900 -55609 -4052931 0 0 0 0 0 0 341978574 0 0.71975 0.73577 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 0 0 0 1 0 1 0 0 0 0 Schedule C, Part II-B, Line 1 Advocacy and coalition participation in support of global health programs. 1635100 0 1635100 28857329 0 3958348 24898981 0 0 0 0 1470811 0 1463319 7492 2664395 0 1839740 824655 27366228 0 Accrued Absences 584877 Payroll Liabilities 4359748 Other Accrued Liabilities 2633727 7578352 X 95120285 0 0 0 0 0 95120285 0 0 0 95120285 93875228 0 0 0 0 0 93875228 52054 0 52054 93927282 Schedule D, Part X, Line 2 Not Applicable 1 Central America and the Caribbean 0 0 Grantmaking 433402 East Asia and the Pacific 0 0 Grantmaking 798437 Europe (including Iceland and Greenland) 0 0 Grantmaking 1477037 North America (including Canada and Mexico, but not the United States) 0 0 Grantmaking 60687 Russia and Neighboring States 0 0 Grantmaking 619188 South America 0 0 Grantmaking 350895 South Asia 0 0 Grantmaking 68810 Sub-Saharan Africa 1 13 Grantmaking 13070901 Middle East and North Africa 0 0 Grantmaking 796379 1 13 17675736 East Asia and the Pacific Neglected Tropical Disease research 255854 Wire transfer 0 N/A N/A Europe (including Iceland and Greenland) Neglected Tropical Disease research 491392 Wire transfer 0 N/A N/A North America (including Canada and Mexico, but not the United States) Neglected Tropical Disease research 60687 Wire transfer 0 N/A N/A South Asia Neglected Tropical Disease research 59811 Wire transfer 0 N/A N/A Sub-Saharan Africa Neglected Tropical Disease research 1712323 Wire transfer 0 N/A N/A South Asia Geospatial analysis of soil transmitted helminthiasis survey Data in Bangladesh 9000 Wire transfer 0 N/A N/A Sub-Saharan Africa Monitoring and evaluation of the soil-transmitted helminthiasis (STH) control programme in Uganda to optimize preventative chemotherapy delivery (Phase II) 42219 Wire transfer 0 N/A N/A Middle East and North Africa Implementation of the 2023 activities of the Global Onchocerciasis Network for Elimination 375830 Wire transfer 0 N/A N/A Sub-Saharan Africa Mwele Malecela Mentorship Program 30000 Wire transfer 0 N/A Sub-Saharan Africa USF-2022-2024 -10 Countries)Laboratory Capacity Building in Africa for Onchocerciasis Elimination/ Supplies/quality control&Processing of required Serological and Molecular 460000 Wire transfer 0 N/A N/A Sub-Saharan Africa Support Hybrid Regional meeting in Accra Ghana-To Review Progress towards the control,Eliminatin of NTD IN West Africa 20050 Wire transfer 0 N/A N/A Sub-Saharan Africa Support the ungoing Transmission of Onchocerciasis 70050 Wire transfer 0 N/A N/A 10 34 Grant funding to complete data testing and or lab research with a final deliverable being a manuscript of thr work Europe (including Iceland and Greenland) 2 26186 Wire transfer 0 N/A N/A Grant funding to complete data testing and or lab research with a final deliverable being a manuscript of the work Middle East and North Africa 2 47800 Wire transfer 0 N/A N/A Grant funding to complete data testing and or lab research with a final deliverable being a manuscript of the work South America 2 8824 Wire transfer 0 N/A N/A Grant funding to complete data testing and or lab research with a final deliverable being a manuscript of the work South Asia 3 50603 Wire transfer 0 N/A N/A Grant funding to complete data testing and or lab research with a final deliverable being a manuscript of the work Sub-Saharan Africa 5 74887 Wire transfer 0 N/A N/A 0 0 0 0 0 1 Schedule F, Part I, Line 2 A Contract is executed with all the required deliverables and budget. Based on work performance, an agreed percentage of the grant is paid to the recipient after receiving an invoice or upon the contract is signed. Subsequent payments are made after the submission of an invoice and a narrative report. Occasionally, there are visits to the countries for feedback and to assess the impact of the project. Budget over-runs have to be explained before a contract amendment, if necessary, is made. X X 0 0 0 0 0 0 0 0 0 David A Ross President & CEO 380847 0 0 0 0 0 23444 0 13434 0 417725 0 0 0 Paul Emerson Program Director 290405 0 17791 0 0 0 27131 0 44937 0 380264 0 0 0 Mark McKinlay Program Director 301101 0 0 0 0 0 25207 0 14777 0 341085 0 0 0 Patrick O'Carroll President & CEO 328667 0 0 0 0 0 27450 0 1287 0 357404 0 0 0 Yao Sodahlon Program Director 253287 0 5125 0 0 0 22706 0 47803 0 328921 0 0 0 William P Nichols Exec. VP/COO 295269 0 0 0 0 0 25833 0 1164 0 322266 0 0 0 John Ward Program Director 287860 0 0 0 0 0 20883 0 1276 0 310019 0 0 0 Carl Reddy Program Director 233677 0 0 0 0 0 21690 0 49847 0 305214 0 0 0 Vivian Singletary Program Director 248374 0 14887 0 0 0 20748 0 31116 0 315125 0 0 0 Joseph Bresee Program Director 264792 0 0 0 0 0 23831 0 301 0 288924 0 0 0 Kris Sarlas Program Director 217226 0 0 0 0 0 18492 0 47947 0 283665 0 0 0 Robert Chen Program Director 259816 0 0 0 0 0 23383 0 1069 0 284268 0 0 0 Patrick Lammie Program Director 244318 0 0 0 0 0 21988 0 966 0 267272 0 0 Ellen Wild Director of Business Strategy 188520 0 0 0 0 0 17073 0 1041 0 206634 0 0 0 Daniel Martins Chief Financial Officer 170785 0 6630 0 2684 0 16124 0 49613 0 245836 0 0 Fabien Diomande Program Director 162511 0 0 0 0 0 15322 0 47581 0 225414 0 0 0 Kent Alexander Board Chair 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Teri Plummer McClure Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Charles H McTier Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 James Jackson Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Deborah Kilpatrick Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Walter Orenstein Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Walter Deriso Jr Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Geeta Manek Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Bushra Sayed-Ganguly Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Form 990, Part VI, Section A, Line 2 The Chief Operating Oficer has a family relationship with a Program Director. Form 990, Part VI, Section B, Line 11b Once the Return is prepared by the CFO, it is reviewed by management and thereafter made available to all board members for any comments, clarifications or corrections. After the board's review, the Return is finalized and filed with the IRS Form 990, Part VI, Section B, Line 12c Board members, officers, and all employees are required to annually sign a declaration that they have read, and have complied with, the Conflict of Interest Policy. Any suspected or reported violations of the policy are to be referred to the COO who would follow-up and investigate the matter Form 990, Part VI, Section B, Line 15 The Task Force for Global Health, Inc. is an affiliate of Emory University and as such, all its employees are in fact Emory employees. For both the President and Exec. VP/COO, Emory includes these positions in its annual market review of compensated professionals in these categories. In addition, performance is measured against goals. Furthermore the board reviews performance including a 360 feedback loop finalizing the President's performance. Form 990, Part VI, Section C, Line 19 Three years of audited financial statements and 990 Tax Returns are posted on the organization's website together with the Conflict of Interest policy and governing documents - Bylaws Global Health Solutions Inc 330 W Ponce de Leon Ave Decatur GA 30030 203674498 Oversees donated pharmaceutical products GA 501 (c)(3) 509(a)(3) Type 1 None 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 Global Health Solutions Inc n 0 Not applicable Global Health Solutions Inc o 0 Not applicable